Condensed Consolidated Interim Statements of Cash Flows - USD ($)		6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net loss	[1]	$ (39,417,299)	$ (50,041,822)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash finance income		(12,920)
Non-cash interest expense		273,554	742,174
Non- cash lease expense		488,299	160,437
Deferred income tax		(109,985)	(102,526)
Depreciation and amortization		3,494,163	1,173,884
Unrealized foreign currency exchange loss		913,101	230,837
Loss on financial instruments, net			40,540,091
Change in deferred revenue		(165,466)	18,302
Non-cash government assistance		(3,047)	(472,499)
Loss on debt settlement			19,253
Gain on sale of property, plant and equipment		(783)
Stock-based compensation		7,623,207	651,718
Non-cash consulting expense		445,664	713,919
Changes in operating assets and liabilities		(2,531,889)	758,381
Net cash used in operating activities		(29,003,401)	(5,607,851)
Cash flows from investing activities:
Purchases of intangible assets			(274,579)
Purchases of property, plant and equipment		(8,971,435)	(3,040,296)
Proceeds from sale of property, plant and equipment		39,140
Proceeds from short-term investments		1,620,281
Acquisition of business, net of cash acquired		(3,486,906)
Proceeds from reverse takeover			146,954,733
Net cash (used in) provided by investing activities		(10,798,920)	143,639,858
Cash flows from financing activities
Proceeds from the issuance of common stock and warrants		50,000,000
Costs paid on the issuance of common stock and warrants		(3,680,666)
Proceeds from long-term debt			1,127,151
Repayments of long-term debt		(182,295)	(53,331)
Proceeds from government grants			223,384
Proceeds from unsecured promissory notes			13,963,386
Proceeds from stock option exercises		305,320	113,155
Proceeds from warrants exercises		169,574	93,993
Proceeds from broker warrants exercises			16,255
Net cash provided by financing activities		46,611,933	15,483,993
Net increase in cash, cash equivalents and restricted cash		6,809,612	153,516,000
Cash, cash equivalents and restricted cash at beginning of the period		47,434,472	1,395,683
Effects of exchange rate changes on cash, cash equivalents and restricted cash		(203,738)	156,367
Cash, cash equivalents and restricted cash at end of the period		54,040,346	155,068,050
Supplemental cash flow information
Accrued purchases of property, equipment, and patents		1,604,903	297,345
Right-of-use assets obtained in exchange for lease liabilities		$ 142,378	1,730,743
Right-of-use assets and prepaid expenses recognized in exchange for common stock			2,149,381
Settlement of liabilities in common stock			52,063,432
Interest paid on debt			$ 64,528

[1] Retroactively restated from the earliest period presented for the Torchlight RTO (“Reverse acquisition”) as described in Note 3